Article Information
History
- March 26, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Emily Hughes, MD1,
- Tamara Van Bakel, BAH2,
- Ashley Raudanskis, BScH1,
- Prachi Ray, BScH1,
- Benazir Hodzic-Santor, BA1,
- Ushma Purohit, MD, MSc1,
- Chana A. Sacks, MD, MPH3 and
- Michael Fralick, MD, PhD1,2,*
- 1Sinai Health System, Division of General Internal Medicine, Toronto, Ontario, Canada
- 2Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada
- 3Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston, USA
- ↵*Correspondence: Michael Fralick, MD, PhD, SM, FRCPC, Sinai Health System 60 Murray Street M5T 3L9, Email (preferred communication method): mike.fralick{at}mail.utoronto.ca, Phone: 416-586-4800
Posted March 26, 2023.
Comparing the clinical trial characteristics of industry-funded trials and non–industry-funded trials
